Furthermore, antrocin, another bioactive constituent of AC, has been found to enhance the sensitivity of prostate cancer cells to radiation therapy by targeting downstream IGF-1R signaling pathways [42]. The gene discussed is IGF1R; the disease is prostate carcinoma.